BD 515105 - BD PhaSeal Protector Closed System Transfer Device, CASE

BD 515105 - BD PhaSeal Protector Closed System Transfer Device, CASE

The BD 515105 BD PhaSeal Protector is a closed system transfer device component designed to help protect healthcare professionals from exposure to hazardous drugs during medication preparation and administration. Manufactured by Becton, Dickinson and Company, the PhaSeal Protector plays a critical role in maintaining a sealed, leak-proof connection within the PhaSeal closed system.

Engineered to mechanically prevent the transfer of environmental contaminants into the system and the escape of hazardous drug vapors or aerosols, the PhaSeal Protector supports safer handling practices in pharmacy and clinical environments where antineoplastic and other hazardous drugs are managed.

Key Benefits

The PhaSeal Protector helps reduce occupational exposure to hazardous drugs by maintaining a fully closed system during drug preparation, transfer, and administration. Its precision-engineered sealing mechanism supports consistent containment, even during pressure changes within the vial or IV system.

Single-use, sterile construction supports infection prevention and eliminates the risks associated with device reuse. The intuitive design allows seamless integration into established PhaSeal workflows without adding complexity for clinical staff.

Key Product Features

Product Packaging Information

Compatibility and Applications

The BD PhaSeal Protector is designed for use exclusively within the BD PhaSeal closed system transfer device portfolio. It connects with compatible PhaSeal components to maintain a closed pathway throughout drug compounding and administration processes.

Typical applications include hazardous drug preparation in hospital pharmacies, oncology infusion centers, cleanrooms, and clinical settings where chemotherapy or other high-risk medications are handled.

Usage Guidelines

The PhaSeal Protector should be used in accordance with facility protocols for hazardous drug handling. It is applied as part of the closed system to ensure a secure, sealed connection before medication transfer begins.

All handling should follow aseptic technique and established USP and institutional guidelines. The device is intended for single use and should be disposed of according to hazardous drug waste and sharps policies after use.

Certifications, Safety Standards, and Regulatory Approvals

The BD PhaSeal system, including the Protector component, is manufactured under quality management systems aligned with FDA medical device regulations and internationally recognized manufacturing standards. PhaSeal devices are widely recognized for meeting the definition of a closed system transfer device under relevant regulatory guidance.

Compliance with these standards supports safer work environments and reinforces confidence in the systems performance in hazardous drug handling.

Comparison with Competitor Products

Compared with open-system transfer methods or partial containment devices, the BD PhaSeal Protector offers full mechanical containment that actively prevents both drug escape and environmental contamination. While some competitor systems rely on filters or partial barriers, PhaSeals sealed design provides a higher level of protection.

Healthcare facilities often select BD PhaSeal products for their long-standing clinical validation, system-wide compatibility, and strong alignment with occupational safety initiatives.

Typical User Profile and Application Scenarios

Typical users include pharmacists, pharmacy technicians, oncology nurses, and trained healthcare professionals involved in the preparation and administration of hazardous medications.

The device is particularly effective in hospital pharmacies, oncology clinics, infusion centers, and cleanroom environments where regulatory compliance and staff safety are top priorities.

Best Practices for Use and Maintenance

Best practice includes ensuring full compatibility with other PhaSeal components and verifying secure connections before medication transfer. Staff should be trained on proper assembly and disposal procedures to maintain system integrity.

As a single-use closed system component, no maintenance or reprocessing is required. Proper disposal after use supports compliance with hazardous drug handling and infection control policies.

Regulatory and Safety Information

The BD 515105 BD PhaSeal Protector is classified as a regulated medical device and supports compliance with hazardous drug handling guidelines and occupational safety standards. Its closed system design aligns with institutional policies aimed at reducing exposure risk.

Following manufacturer instructions and facility procedures is essential to ensure safe, compliant use in all approved applications.

How to Order

The BD 515105 BD PhaSeal Protector is available for purchase through the CIA Medical website. Add the product to your cart and proceed through the secure checkout process.

For bulk purchasing, oncology program support, or additional assistance, contact CIA Medical customer service at 312 275 5850 or use the contact form available on this page for prompt support.